As per the latest report by IMARC Group, titled “Dry Eye Syndrome Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2020-2025”, the global dry eye syndrome market reached a value of US$ 3.7 Billion in 2019. Dry eye syndrome, also known as keratoconjunctivitis sicca (KCS), refers to a condition in which the patient experiences a lack of lubrication or moisture on the surface of their eyes. The symptoms include aching and burning sensations, soreness, redness, fatigue, and itching in the eyes, along with photophobia. Moreover, watery eyes can also be a symptom of this condition as the dry eye surface can over-stimulate the production of the watery component of tears to reduce dryness.
Global Dry Eye Syndrome Market Trends:
Reliance on electronic gadgets like computers and smartphones is one of the primary factors increasing the prevalence of dry eye syndrome. Prolonged usage of these devices results in strained eyes, diminished visual alertness, and mucosal dryness or burning sensation. Additionally, continuous staring at these devices can decrease the stability of the tear film and cause ocular discomfort. Apart from this, numerous diseases, such as diabetes, thyroid disorders, Sjogren’s syndrome, lupus, scleroderma and rheumatoid arthritis, increase the chances of developing dry eyes among patients. As per statistics, approximately 425-430 million individuals around the world get affected by diabetes. It causes constant changes in the composition of the patient’s blood, thereby adversely affecting their tear glands. Looking forward, the global dry eye syndrome market to exhibit moderate growth during 2020-2025.
Get a PDF Sample for more detailed market insights: https://www.imarcgroup.com/dry-eye-syndrome-market/requestsample
Note: We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report.
Global Dry Eye Syndrome Market 2020-2025 Analysis and Segmentation:
The competitive landscape of the market has been studied in the report with the detailed profiles of the key players operating in the market.
Some of the key players being Nicox S.A., Allergan plc., Novartis AG, Otsuka Holdings Co., Ltd., Santen Pharmaceutical Co., Ltd., Auven Therapeutics, Akorn, Inc., Bausch + Lomb, Alimera Science and GlaxoSmithKline Plc.
For more information about this report visit: https://www.imarcgroup.com/dry-eye-syndrome-market
The report has segmented the market on the basis of Product, Disease Type, Drug Type, Distribution Channel and Region.
Breakup by Disease Type
1. Evaporative Dry Eye Syndrome
2. Aqueous Dry Eye Syndrome
Breakup by Drug Type
1. Lubricant Eye Drops
2. Anti-inflammatory Drugs
3. Autologous Serum Eye Drops
Breakup by Product
1. Liquid Drops
3. Liquid Wipes
4. Eye Ointment
Breakup by Distribution Channel
1. Retail Pharmacies
2. Hospital Pharmacies
3. Online Pharmacies
Breakup by Region
1. North America
3. Asia Pacific
4. Middle East and Africa
5. Latin America
If you want to need latest primary and secondary data (2020-2025) with Cost Module, Business Strategy, Distribution Channel, etc. Click request free sample report, published report will be delivered to you in PDF format via email within 24 to 48 hours of receiving full payment.
Other Report by IMARC Group:
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
30 N Gould St Ste R
Sheridan, WY 82801 USA
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800